Delivery Order SPE2DB22D3301-SPE2DB24FY1UJ
- Not listed
- This federal contract award, with an ID of SPE2DB25D3005|SPE2DB25FQCGX, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567201694 ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,705.82 and a period of performance through February 7, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
- This federal contract award, with ID SPE2DB24D1034|SPE2DB25FWAB2, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567057625 ! ONDANSETRON ODT 8 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $19,546.28. The contract has a firm fixed price pricing type and an ultimate completion date of January 28, 2025. This contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,905.07, is for the delivery of 4567780857 ONDANSETRON ODT 8 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025 and is a Firm Fixed Price Delivery Order. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4567795620 ONDANSETRON ODT 8 MG TABLET 30S. The contract has a ceiling value of $5,367.06 and is a Firm Fixed Price Delivery Order with an ultimate completion date of April 4, 2025. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award, with an ID of SPE2DB22D2005|SPE2DB23FJPF6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4560956554 - ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $10,571.92 and a completion date of May 17, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This federal contract award, valued at $3,923.08, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563755997 ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, with a completion date of February 26, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565583658 ONDANSETRON ODT 4 MG TABLET 30S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,698.08 and an ultimate completion date of August 27, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, through its Corporate Office Division, has been...
- This federal contract award with ID SPE2DB20D1100|SPE2DB24FB5B1 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $5,981.44, is for the delivery of 4564435295 ! ONDANSETRON ODT 4 MG TABLET 30S. The contract has a firm fixed price pricing type and an ultimate completion date of April 30, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award, with an ID of SPE2DB24D2003|SPE2DB25FXGF0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4567693529 ONDANSETRON ODT 4 MG TABLET 30S, with a ceiling value of $2,673.16 and a firm fixed price contract type. The contract has an ultimate completion date of March 26, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, with an ID of SPE2DB22D3501|SPE2DB25FUR11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567342691 ONDANSETRON ODT 4 MG TABLET 30S, with a ceiling value of $5,514.09 and a completion date of February 24, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a for-profit...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY1UJDelivery Order
This federal contract award, with an ID of SPE2DB22D3301|SPE2DB24FY1UJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4563830691 - ONDANSETRON ODT 8 MG TABLET 30S, a pharmaceutical product, with a firm fixed price ceiling value of $2,532.07 and a completion date of March 4, 2024. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor on this order. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 3/1/24 |